ENGLISH
|
JAPANESE
|
CONNECT WITH US:
Home
About
Contact
Log in
*
Home
Press release
Jul 27, 2021 09:00 JST
Source:
Cryoviva Singapore
Singapore cord blood bank Cryoviva establishes footprint in the UAE
Builds on a strong foundations in Singapore to help families in Dubai and the UAE benefit from the growing interest and acceptance of cord component storage for possible stem cell treatments later on. Many families in the UAE have opted to store their baby's cord blood in Cryoviva's facility in Singapore.
Singapore, Jul 27, 2021 - (ACN Newswire) - Family cord blood bank Cryoviva Singapore is pleased to announce that it has made a successful foray into the UAE market in line with its strategic growth plans. After 7 years of serving young families in Singapore, the expansion into Dubai and the other Emirates in the UAE is an important milestone for Cryoviva.
Rajesh Nair, CEO of Cryoviva Singapore
"This is an important step in our journey, fulfilling our mission to give every family the chance to benefit from the medical potential of cord stem cells should they need it. That we have been able to attract young families in the UAE to trust us with their baby's precious cord blood is not only a testament to our credentials as a company, but also to Singapore's reputation for world-class facilities and strict adherence to high-quality standards. We invite healthcare providers offering maternity services to collaborate with us to provide even greater service to their valued patients," said Rajesh Nair, CEO of Cryoviva Singapore.
"While we continue with our growth efforts in several other countries - both in the ASEAN region as well as in the Middle East, I would also like to reiterate our commitment to serving families in Singapore. We believe that there is still considerable potential for family cord blood banking services to grow in a developed and discerning market like Singapore. We also look forward to contributing to further our city's position as a great destination to avail of world-class healthcare services."
About Cryoviva Singapore
Established in 2014, Cryoviva (
https://cryoviva.com.sg
) is a well-regarded family cord blood bank in Singapore. The company is part of an international group backed by multinational investors. The Cryoviva group has successfully stored over 160,000 cord blood units. Cryoviva's cord blood storage facility in Singapore is MoH-licensed, AABB accredited and IS ISO 9001:2015 QMS Certified, testaments to the stringent processes and quality standards that it adheres to. With its central location and proximity to most major maternity hospitals in Singapore, cord blood samples reach our facilities quickly and efficiently to ensure top quality maintenance upon storage.
Media Contact:
Krish Sharma, General Manager
Cryoviva Singapore,
Tel: +65-9651 7080
E-mail:
krish@cryoviva.com.sg
Source: Cryoviva Singapore
Sectors: BioTech, Healthcare & Pharm, Clinical Trials
Copyright ©2025 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
Latest Release
TANAKA PRECIOUS METAL GROUP Announces Business Partnership with JEPLAN to Realize a Decarbonized, Circular Society
Jul 31, 2025 15:00 JST
DENSO Announces First Quarter Financial Results
Jul 31, 2025 11:25 JST
Honda Launches All-New Prelude Teaser Page Ahead of Scheduled September 2025 Market Introduction
Jul 31, 2025 11:20 JST
MHI Demonstrates Transport of Relief Supplies in the Event of a Disaster Using Uncrewed Aerial Vehicles Currently in Development
Jul 31, 2025 11:00 JST
Early Alzheimer's Patients Continue to Benefit from Four Years of LEQEMBI(R) (lecanemab-irmb) Therapy New Clinical Data Presented at AAIC
Jul 31, 2025 09:30 JST
New Data Presented at AAIC Demonstrates Investigational LEQEMBI(R) (lecanemab-irmb) 360 mg Subcutaneous Maintenance Dosing Could Offer a New Option for Ongoing Treatment of Early Alzheimer's Disease
Jul 31, 2025 09:20 JST
Two-Year Real-World Study of LEQEMBI(R) in the United States Presented at Alzheimer's Association International Conference (AAIC) 2025
Jul 31, 2025 09:10 JST
Introducing the Meshy 5 Preview: Smarter AI, Cleaner Models, Bigger Animation Potential
Jul 30, 2025 22:41 JST
Production, Sales and Export Results for June, 2025
Jul 30, 2025 18:24 JST
Sales, Production, and Export Results for the First Half of 2025
Jul 30, 2025 18:06 JST
Collaborative Development of Ultra-Compact and Lightweight Satellite Communication User Terminals for Mobility with Mitsubishi Chemical, NICT, and TECHLAB
Jul 30, 2025 11:00 JST
Mitsubishi Heavy Industries Concludes Agreement with Modius to Provide DCIM Solutions for Data Centers Worldwide
Jul 29, 2025 20:00 JST
Set at the Osaka-Kansai Expo venue! Detailed program announced for the "OSAKA JAPAN SDGs Forum"
Jul 29, 2025 14:30 JST
LENVIMA(R) (lenvatinib) in Combination with Pembrolizumab and Transarterial Chemoembolization (TACE) Approved in China for the Treatment of Unresectable, Non-Metastatic Hepatocellular Carcinoma
Jul 29, 2025 09:01 JST
Olympus Enters Strategic Partnership to Develop Endoluminal Gastrointestinal Robotics
Jul 25, 2025 16:00 JST
Eisai Listed for 24th Consecutive Year in FTSE4Good Index Series, an Index for Socially Responsible Investment
Jul 25, 2025 13:31 JST
Fujitsu and Nagoya University develop simulation tech to combat transportation gaps
Jul 24, 2025 12:30 JST
Honda Reveals Details of its Support of the World Athletics Championships Tokyo 25
Jul 24, 2025 12:03 JST
Prototype divertor outer vertical target for the ITER fusion experimental reactor is completed and the sample has passed the ITER Organization's certification test
Jul 23, 2025 13:10 JST
Sharp Exhibits at the 2nd SPEXA - International Space Business Expo
Jul 23, 2025 10:30 JST
More Latest Release >>
Related Release
Singapore family cord blood bank Cryoviva upgrades to AXP II System for cord blood processing
March 21 2023 08:30 JST
Cryoviva Singapore Gets AABB Accreditation for Somatic Cells' Processing, Storage, and Distribution
November 02 2021 08:30 JST
Cryoviva Singapore Expands Cord Blood Banking Services to Bahrain
September 07 2021 12:20 JST
More Press release >>